NeuroVista Receives $16,500,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24851999-996b-4bf7-adf3-b79751341719&Preview=1 - Date
8/25/2010 - Company Name
NeuroVista - Mailing Address
100 Fourth Ave North Seattle, WA 98109 - Company Description
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy. Epilepsy is a neurological condition affecting approximately 1% of the U.S. population – more than Parkinson’s disease, multiple sclerosis and Lou Gehrig’s disease combined. - Website
http://www.neurovista.com - Transaction Type
Venture Equity - Transaction Amount
$16,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
GBS Venture Partners - Venture Investor
Advanced Technology Ventures - Venture Investor
Delphi Ventures - Venture Investor
Foundation Medical Partners
